{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:02:04Z","timestamp":1780920124627,"version":"3.54.1"},"reference-count":35,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Urinary tract infections (UTIs) represent one of the most frequently encountered bacterial infections in clinical practice. Although vitamin D (vit D) is recognised for its immunomodulatory properties, its relationship with the spectrum of uropathogens remains unclear. This study investigated the distribution of UTI-causing pathogens in relation to serum vit D status and demographic variables including age, sex, season, and year of presentation at a tertiary hospital in the Eastern Mediterranean. Materials and Methods: A retrospective cross-sectional analysis was conducted on 942 adult patients with culture-confirmed UTIs at a university hospital in Cyprus between January 2019 and December 2024. Serum 25-hydroxyvitamin D [25(OH)D] levels were classified as deficient (\u226420 ng\/mL), insufficient (20\u201329.9 ng\/mL), or sufficient (\u226530 ng\/mL) according to Turkish Endocrinology Society (TEMD) guidelines. Pathogen distribution was correlated with vit D category, sex, age group, season, and year using chi-square analysis and multivariable logistic regression. Timing of urine culture collection (at admission vs. more than 48 h after admission), catheter use, upper vs. lower urinary tract classification, and comorbidity data were recorded for each patient. Results: Escherichia coli was the most frequently isolated uropathogen (48.83%), followed by Klebsiella pneumoniae (18.79%) and Enterococcus faecalis (11.89%). No statistically significant association was found between vit D level and uropathogen type (p = 0.504). Infections were more prevalent in females (70.49%) and in patients aged over 70 years (56.26%). Vit D deficiency was present in 47.98% of the cohort. Catheter-derived specimens accounted for 35.1% of cultures. Upper tract infection was diagnosed in 233 patients (24.7%) and lower tract infection in 709 patients (75.3%). The most frequent comorbidities were hypertension (48.4%), diabetes mellitus (33.1%), and chronic kidney disease (21.0%); on multivariable analysis, diabetes mellitus (adjusted OR = 1.4) and chronic kidney disease (adjusted OR = 1.6) were independently associated with K. pneumoniae infection. In vit D-deficient patients, K. pneumoniae infection risk was significantly higher during winter in unadjusted analysis (OR = 1.8; 95% CI: 1.3\u20132.5) and remained elevated after multivariable adjustment (aOR = 1.6; 95% CI: 1.1\u20132.3). Vit D levels showed significant seasonal variation (p &lt; 0.001), with lower values in winter (18.6 ng\/mL) and higher values in summer (28.4 ng\/mL). Conclusions: On multivariable analysis, no statistically significant association was found between vit D level and uropathogen species overall (\u03c72 = 13.291; p = 0.504); a seasonal interaction was observed between vit D deficiency and Klebsiella infections in winter. UTI risk was highest in elderly and female patients. These findings point to the need for considering seasonal and dietary factors in UTI management and call for prospective investigation.<\/jats:p>","DOI":"10.3390\/medicina62061113","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:04:14Z","timestamp":1780913054000},"page":"1113","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin D Levels and Uropathogen Distribution in Urinary Tract Infections: A Six-Year Retrospective Study from Cyprus"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0085-7470","authenticated-orcid":false,"given":"H\u00fclya","family":"Ar\u0131k","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Near East University, 99138 Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap","family":"T\u0131nazl\u0131","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, Near East University, 99138 Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaya","family":"S\u00fcer","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, School of Medicine, Near East University, 99138 Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1756287219832172","DOI":"10.1177\/1756287219832172","article-title":"An introduction to the epidemiology and burden of urinary tract infections","volume":"11","author":"Medina","year":"2019","journal-title":"Ther. Adv. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Walker","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/S0002-9343(02)01055-0","article-title":"The etiology of urinary tract infection: Traditional and emerging pathogens","volume":"113","author":"Ronald","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"f3140","DOI":"10.1136\/bmj.f3140","article-title":"Diagnosis and management of recurrent urinary tract infections in non-pregnant women","volume":"346","author":"Gupta","year":"2013","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/derm.3.4.15027","article-title":"Antimicrobial implications of vitamin D","volume":"3","author":"Youssef","year":"2011","journal-title":"Dermatoendocrinology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Charoenngam, N., and Holick, M.F. (2020). Immunologic effects of vitamin D on human health and disease. Nutrients, 12.","DOI":"10.3390\/nu12072097"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on cathelicidin induction","volume":"179","author":"Liu","year":"2007","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gombart, A.F., Pierre, A., and Maggini, S. (2020). A review of micronutrients and the immune system\u2014Working in harmony to reduce the risk of infection. Nutrients, 12.","DOI":"10.3390\/nu12010236"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5152\/ABCR.2021.21001","article-title":"Relationship between vitamin D and recurrent urinary tract infections in premenopausal women","volume":"3","author":"Kara","year":"2021","journal-title":"Arch. Basic Clin. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1121","DOI":"10.1016\/j.ijid.2013.06.007","article-title":"The association between serum levels of vitamin D and recurrent urinary tract infections in premenopausal women","volume":"17","author":"Nseir","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"i6583","DOI":"10.1136\/bmj.i6583","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau","year":"2017","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/23744235.2016.1201853","article-title":"Prevention of urinary tract infections with vitamin D supplementation 20,000 IU per week for five years: Results from a randomized clinical trial with 511 participants","volume":"48","author":"Jorde","year":"2016","journal-title":"Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Grant, W.B., Lahore, H., McDonnell, S.L., Baggerly, C.A., French, C.B., Aliano, J.L., and Bhattoa, H.P. (2020). Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients, 12.","DOI":"10.20944\/preprints202003.0235.v2"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mercola, J., Grant, W.B., and Wagner, C.L. (2020). Evidence regarding vitamin D and risk of COVID-19 and its severity. Nutrients, 12.","DOI":"10.3390\/nu12113361"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/315827","article-title":"Risk factors for recurrent urinary tract infection in young women","volume":"182","author":"Scholes","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMcp1104429","article-title":"Clinical practice. Uncomplicated urinary tract infection","volume":"366","author":"Hooton","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cger.2016.03.002","article-title":"Urinary tract infections in the elderly","volume":"32","author":"Nicolle","year":"2016","journal-title":"Clin. Geriatr. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2014.303","article-title":"Urinary tract infections in older women","volume":"311","author":"Mody","year":"2014","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199608153350703","article-title":"A prospective study of risk factors for symptomatic urinary tract infection in young women","volume":"335","author":"Hooton","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","article-title":"Prevalence and correlates of vitamin D deficiency in US adults","volume":"31","author":"Forrest","year":"2011","journal-title":"Nutr. Res."},{"key":"ref_23","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2023). Performance Standards for Antimicrobial Susceptibility Testing, CLSI. [33rd ed.]. CLSI Supplement M100."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.nutres.2014.12.008","article-title":"Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review","volume":"35","author":"Silva","year":"2015","journal-title":"Nutr. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1258\/acb.2011.011195","article-title":"Serum 25-hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction","volume":"49","author":"Barth","year":"2012","journal-title":"Ann. Clin. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Moradali, M.F., Ghods, S., and Rehm, B.H.A. (2017). Pseudomonas aeruginosa lifestyle: A paradigm for adaptation, survival, and persistence. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00039"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the NHSN at the CDC, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOU.0000000000000364","article-title":"An update on classification and management of urosepsis","volume":"27","author":"Wagenlehner","year":"2017","journal-title":"Curr. Opin. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: An emerging public health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"Doi","year":"2017","journal-title":"Virulence"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1093\/cid\/ciaa1478","article-title":"IDSA guidance on the treatment of ESBL-E, CRE, and DTR-P. aeruginosa","volume":"72","author":"Tamma","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","first-page":"111","article-title":"Near future perspective of ESBL-producing Klebsiella pneumoniae strains using mathematical modelling","volume":"130","author":"Kaymakamzade","year":"2022","journal-title":"CMES Comput. Model. Eng. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.euf.2016.11.001","article-title":"The urinary tract microbiome in health and disease","volume":"4","author":"Castillo","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/s41467-019-13467-w","article-title":"Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection","volume":"10","author":"Magruder","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00394-015-0966-2","article-title":"Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract","volume":"55","author":"Bashir","year":"2016","journal-title":"Eur. J. Nutr."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1113\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:15:08Z","timestamp":1780917308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/6\/1113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medicina62061113"],"URL":"https:\/\/doi.org\/10.3390\/medicina62061113","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}